Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies

Sturm, 2014, Multiple sclerosis: a review of the disease and treatment options, Consult Pharm, 29, 469, 10.4140/TCP.n.2014.469 Milo, 2014, Revised diagnostic criteria of multiple sclerosis, Autoimmun Rev, 13, 518, 10.1016/j.autrev.2014.01.012 Flachenecker, 2003, Fatigue in MS is related to sympathetic vasomotor dysfunction, Neurology, 61, 851, 10.1212/01.WNL.0000080365.95436.B8 Flachenecker, 1999, Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intolerance, J Neurol, 246, 578, 10.1007/s004150050407 Flachenecker, 2001, Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability, Mult Scler, 7, 327, 10.1177/135245850100700509 Sternberg, 2012, Sympathetic nervous system dysfunction in multiple sclerosis, linking neurodegeneration to a reduced response to therapy, Curr Pharm Des, 18, 1635, 10.2174/138161212799958639 Sternberg, 2012, Autonomic dysfunction: a unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein–Barr virus, Autoimmun Rev, 12, 250, 10.1016/j.autrev.2012.04.004 Aune, 2000, Evidence of dysfunctional beta2-adrenoceptor signal system in pre-eclampsia, BJOG, 107, 116, 10.1111/j.1471-0528.2000.tb11587.x Fraussen, 2014, Targets of the humoral autoimmune response in multiple sclerosis, Autoimmun Rev, 13, 1126, 10.1016/j.autrev.2014.07.002 Elenkov, 2000, The sympathetic nerve—an integrative interface between two supersystems: the brain and the immune system, Pharmacol Rev, 52, 595 Simonini, 2010, Increasing CNS noradrenaline reduces EAE severity, J Neuroimmune Pharmacol, 5, 252, 10.1007/s11481-009-9182-2 Hashioka, 2007, Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide, Exp Neurol, 206, 33, 10.1016/j.expneurol.2007.03.022 Wang, 2014, Genipin is active via modulating monoaminergic transmission and levels of brain-derived neurotrophic factor (BDNF) in rat model of depression, Neuroscience, 275, 365, 10.1016/j.neuroscience.2014.06.032 Kodounis, 2005, Measurement of autonomic dysregulation in multiple sclerosis, Acta Neurol Scand, 112, 403, 10.1111/j.1600-0404.2005.00446.x Carter, 2003, The effect of age and gender on heart rate variability after endurance training, Med Sci Sports Exerc, 35, 1333, 10.1249/01.MSS.0000079046.01763.8F Khoury, 2010, A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis, Arch Neurol, 67, 1055, 10.1001/archneurol.2010.222 Taneja, 2005, Modafinil elicits sympathomedullary activation, Hypertension, 45, 612, 10.1161/01.HYP.0000158267.66763.63 Niepel, 2013, Association of a deficit of arousal with fatigue in multiple sclerosis: effect of modafinil, Neuropharmacology, 64, 380, 10.1016/j.neuropharm.2012.06.036 Rammohan, 2002, Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study, J Neurol Neurosurg Psychiatry, 72, 179, 10.1136/jnnp.72.2.179 Bruce, 2012, Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study, Cogn Behav Neurol, 25, 107, 10.1097/WNN.0b013e31826df7fd Grubb, 1998, Antagonist precipitated clonidine withdrawal in rat: effects on locus coeruleus neurons, sympathetic nerves and cardiovascular parameters, J Auton Nerv Syst, 71, 85, 10.1016/S0165-1838(98)00065-4 Savola, 2003, Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease, Mov Disord, 18, 872, 10.1002/mds.10464 Lu, 2008, The neuroprotective effect of antidepressant drug via inhibition of TIEG2-MAO B mediated cell death, Drug Discov Ther, 2, 289 Licht, 2010, Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability, Biol Psychiatry, 68, 861, 10.1016/j.biopsych.2010.06.032 Goldstein, 2006, l-Dihydroxyphenylserine (l-DOPS): a norepinephrine prodrug, Cardiovasc Drug Rev, 24, 189, 10.1111/j.1527-3466.2006.00189.x Sommerauer, 2012, The noradrenaline transporter as site of action for the anti-Parkinson drug amantadine, Neuropharmacology, 62, 1708, 10.1016/j.neuropharm.2011.11.017 Shaygannejad, 2012, Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study, Neurol Res, 34, 854, 10.1179/1743132812Y.0000000081 Sailer, 2000, Amantadine influences cognitive processing in patients with multiple sclerosis, Pharmacopsychiatry, 33, 28, 10.1055/s-2000-7966 Huber, 1999, Possible use of amantadine in depression, Pharmacopsychiatry, 32, 47, 10.1055/s-2007-979191 Lupp, 1992, Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-d-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro, J Pharmacol Exp Ther, 263, 717 Riise, 2003, Smoking is a risk factor for multiple sclerosis, Neurology, 61, 1122, 10.1212/01.WNL.0000081305.66687.D2 Wingerchuk, 2012, Smoking: effects on multiple sclerosis susceptibility and disease progression, Ther Adv Neurol Disord, 5, 13, 10.1177/1756285611425694 Hedstrom, 2009, Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis, Neurology, 73, 696, 10.1212/WNL.0b013e3181b59c40 Conti-Tronconi, 1994, The nicotinic acetylcholine receptor: structure and autoimmune pathology, Crit Rev Biochem Mol Biol, 29, 69, 10.3109/10409239409086798 Galzi, 1995, Neuronal nicotinic receptors: molecular organization and regulations, Neuropharmacology, 34, 563, 10.1016/0028-3908(95)00034-4 Klimek, 2001, Effects of long-term cigarette smoking on the human locus coeruleus, Arch Gen Psychiatry, 58, 821, 10.1001/archpsyc.58.9.821 Laustiola, 1988, Decreased beta-adrenergic receptor density and catecholamine response in male cigarette smokers. A study of monozygotic twin pairs discordant for smoking, Circulation, 78, 1234, 10.1161/01.CIR.78.5.1234 Karakaya, 2007, Acute effect of cigarette smoking on heart rate variability, Angiology, 58, 620, 10.1177/0003319706294555 Mitchell, 1993, Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release, Neuroscience, 56, 989, 10.1016/0306-4522(93)90145-6 Shearman, 2005, Locally administered low nicotine-induced neurotransmitter changes in areas of cognitive function, Neurochem Res, 30, 1055, 10.1007/s11064-005-7132-9 Benowitz, 2009, Nicotine chemistry, metabolism, kinetics and biomarkers, Handb Exp Pharmacol, 29–60, 10.1007/978-3-540-69248-5_2 Hedstrom, 2013, Nicotine might have a protective effect in the etiology of multiple sclerosis, Mult Scler, 19, 1009, 10.1177/1352458512471879 Aharoni, 2013, The mechanism of action of glatiramer acetate in multiple sclerosis and beyond, Autoimmun Rev, 12, 543, 10.1016/j.autrev.2012.09.005 Kieseier, 2011, The mechanism of action of interferon-beta in relapsing multiple sclerosis, CNS Drugs, 25, 491, 10.2165/11591110-000000000-00000 Bender, 2006, Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use, Pharmacol Rev, 58, 488, 10.1124/pr.58.3.5 Gonzalez-Garcia, 2013, Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis, Br J Pharmacol, 170, 602, 10.1111/bph.12308 Chen, 2010, Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats, Brain Res, 1309, 116, 10.1016/j.brainres.2009.10.054 Medina-Rodriguez, 2013, Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival, Cell Mol Life Sci, 70, 3449, 10.1007/s00018-013-1340-2 Dinter, 2000, Phosphodiesterase type 4 inhibitors: potential in the treatment of multiple sclerosis?, BioDrugs, 13, 87, 10.2165/00063030-200013020-00002 Bielekova, 2009, Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood–brain barrier disruption in multiple sclerosis, Mult Scler, 15, 1206, 10.1177/1352458509345903 Kawasaki, 1992, Effect of ibudilast: a novel antiasthmatic agent, on airway hypersensitivity in bronchial asthma, J Asthma, 29, 245, 10.3109/02770909209048938 Ohashi, 1986, A new vasodilator 3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine (KC-404) has a dual mechanism of action on platelet aggregation, Arch Int Pharmacodyn Ther, 283, 321 Barkhof, 2010, Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?, Neurology, 74, 1033, 10.1212/WNL.0b013e3181d7d651 Suzumura, 2000, Drop in relapse rate of MS by combination therapy of three different phosphodiesterase inhibitors, Mult Scler, 6, 56, 10.1177/135245850000600111 Heystek, 2003, Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity, Int Immunol, 15, 827, 10.1093/intimm/dxg079 Syed, 2013, Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination, EMBO Mol Med, 5, 1918, 10.1002/emmm.201303123 Priem, 2013, Influence of phosphodiesterases on basal and 5-HT(4) receptor facilitated cholinergic contractility in pig descending colon, Eur J Pharmacol, 705, 156, 10.1016/j.ejphar.2013.02.011 Townsend, 2013, Quercetin acutely relaxes airway smooth muscle and potentiates beta-agonist-induced relaxation via dual phosphodiesterase inhibition of PLCbeta and PDE4, Am J Physiol Lung Cell Mol Physiol, 305, L396, 10.1152/ajplung.00125.2013 Eubanks, 2006, A molecular link between the active component of marijuana and Alzheimer's disease pathology, Mol Pharm, 3, 773, 10.1021/mp060066m Shaked, 2009, MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase, Immunity, 31, 965, 10.1016/j.immuni.2009.09.019 Singer, 2006, Acetylcholinesterase inhibition in patients with orthostatic intolerance, J Clin Neurophysiol, 23, 476, 10.1097/01.wnp.0000229946.01494.4c Krupp, 2011, Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis, Neurology, 76, 1500, 10.1212/WNL.0b013e318218107a Maurer, 2013, Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients, Mult Scler, 19, 631, 10.1177/1352458512463481 Virta, 2011, Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment, Mult Scler, 17, 931, 10.1177/1352458511399613 Epstein, 2014, Characterization of cognitive dysfunction in Sjogren's syndrome patients, Clin Rheumatol, 33, 511, 10.1007/s10067-013-2453-6 Sakakibara, 2014, MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review, Parkinsonism Relat Disord, 20, 267, 10.1016/j.parkreldis.2013.11.001 Gibbons, 2012, Autoimmune autonomic ganglionopathy with reversible cognitive impairment, Arch Neurol, 69, 461, 10.1001/archneurol.2011.2372 Frith, 2012, Cognitive symptoms are common in immune thrombocytopenia and associate with autonomic symptom burden, Eur J Haematol, 88, 224, 10.1111/j.1600-0609.2011.01730.x Saint Martin, 2013, Baroreflex sensitivity, vascular risk factors, and cognitive function in a healthy elderly population: the PROOF cohort, J Am Geriatr Soc, 61, 2096, 10.1111/jgs.12548 Zeki Al Hazzouri, 2014, Reduced heart rate variability is associated with worse cognitive performance in elderly Mexican Americans, Hypertension, 63, 181, 10.1161/HYPERTENSIONAHA.113.01888 Frewen, 2013, Cognitive function is associated with impaired heart rate variability in ageing adults: the Irish longitudinal study on ageing wave one results, Clin Auton Res, 23, 313, 10.1007/s10286-013-0214-x Marti, 1996, Erythropoietin gene expression in human, monkey and murine brain, Eur J Neurosci, 8, 666, 10.1111/j.1460-9568.1996.tb01252.x Siren, 2001, Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain, Acta Neuropathol, 101, 271, 10.1007/s004010000297 Ehrenreich, 2004, Erythropoietin: a candidate compound for neuroprotection in schizophrenia, Mol Psychiatry, 9, 42, 10.1038/sj.mp.4001442 Eid, 2004, Increased expression of erythropoietin receptor on blood vessels in the human epileptogenic hippocampus with sclerosis, J Neuropathol Exp Neurol, 63, 73, 10.1093/jnen/63.1.73 Ehrenreich, 2008, Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition, J Ren Nutr, 18, 146, 10.1053/j.jrn.2007.10.029 Byts, 2009, Erythropoietin: a multimodal neuroprotective agent, Exp Transl Stroke Med, 1, 4, 10.1186/2040-7378-1-4 Konishi, 1993, Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo, Brain Res, 609, 29, 10.1016/0006-8993(93)90850-M Koshimura, 1999, Effects of erythropoietin on neuronal activity, J Neurochem, 72, 2565, 10.1046/j.1471-4159.1999.0722565.x Viviani, 2005, Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor, J Neurochem, 93, 412, 10.1111/j.1471-4159.2005.03033.x Yamamoto, 2000, Stimulating effect of erythropoietin on the release of dopamine and acetylcholine from the rat brain slice, Neurosci Lett, 292, 131, 10.1016/S0304-3940(00)01441-5 Agnello, 2002, Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis, Brain Res, 952, 128, 10.1016/S0006-8993(02)03239-0 Brines, 2000, Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury, Proc Natl Acad Sci U S A, 97, 10526, 10.1073/pnas.97.19.10526 Li, 2004, Beneficial effect of erythropoietin on experimental allergic encephalomyelitis, Ann Neurol, 56, 767, 10.1002/ana.20274 Savino, 2006, Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis, J Neuroimmunol, 172, 27, 10.1016/j.jneuroim.2005.10.016 Yuan, 2008, Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE, PLoS One, 3, e1924, 10.1371/journal.pone.0001924 Kang, 2010, Comorbidities amongst patients with multiple sclerosis: a population-based controlled study, Eur J Neurol, 17, 1215, 10.1111/j.1468-1331.2010.02971.x Wang, 2013, Erythropoietin levels in patients with multiple sclerosis complicated with anemia, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 35, 84 Gangat, 2013, Anemia of chronic disease, Semin Hematol, 50, 232, 10.1053/j.seminhematol.2013.06.006 Alanoglu, 2007, Autoimmune hemolytic anemia during interferon-beta-I b treatment for multiple sclerosis, Mult Scler, 13, 683, 10.1177/1352458506071333 Ganong, 1973, Biogenic amines, sympathetic nerves, and renin secretion, Fed Proc, 32, 1782 Bulloch, 1985, Neuroanatomy of lymphoid tissue, 111 Bazan, 1991, Neuropoietic cytokines in the hematopoietic fold, Neuron, 7, 197, 10.1016/0896-6273(91)90258-2 Obayashi, 2000, Mechanism of anemia associated with autonomic dysfunction in rats, Auton Neurosci, 82, 123, 10.1016/S0165-1838(00)00099-0 Brown, 1977, Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation, J Clin Invest, 60, 70, 10.1172/JCI108771 Beckman, 1979, Changes in beta-2 adrenergic receptor sensitivity with maturation of erythroid progenitor cells, Experientia, 35, 1671, 10.1007/BF01953262 Dresch, 1981, Effect of beta adrenergic agonists and beta blocking agents on hemopoiesis in human bone marrow, Biomedicine, 34, 93 Mladenovic, 1984, Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man, Br J Haematol, 56, 323, 10.1111/j.1365-2141.1984.tb03959.x Ehrenreich, 2007, Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis, Brain, 130, 2577, 10.1093/brain/awm203 Hand, 1995, Erythropoietin enhances vascular responsiveness to norepinephrine in renal failure, Kidney Int, 48, 806, 10.1038/ki.1995.354 Asahara, 1993, Secondary hypoplastic anemia in patients with familial amyloidotic polyneuropathy, Acta Haematol, 90, 130, 10.1159/000204393 Biaggioni, 1994, The anemia of primary autonomic failure and its reversal with recombinant erythropoietin, Ann Intern Med, 121, 181, 10.7326/0003-4819-121-3-199408010-00004 Ando, 1996, Autonomic dysfunction and anemia in neurologic disorders, J Auton Nerv Syst, 61, 145, 10.1016/S0165-1838(96)00070-7 Dai, 2010, Mediterranean dietary pattern is associated with improved cardiac autonomic function among middle-aged men: a twin study, Circ Cardiovasc Qual Outcomes, 3, 366, 10.1161/CIRCOUTCOMES.109.905810 Christensen, 2001, Marine n−3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography, Circulation, 103, 651, 10.1161/01.CIR.103.5.651 Christensen, 2005, Alpha-linolenic acid and heart rate variability in women examined for coronary artery disease, Nutr Metab Cardiovasc Dis, 15, 345, 10.1016/j.numecd.2004.09.005 Park, 2009, Fruit, vegetable, and fish consumption and heart rate variability: the Veterans Administration Normative Aging Study, Am J Clin Nutr, 89, 778, 10.3945/ajcn.2008.26849 Nordvik, 2000, Effect of dietary advice and n−3 supplementation in newly diagnosed MS patients, Acta Neurol Scand, 102, 143, 10.1034/j.1600-0404.2000.102003143.x Torkildsen, 2012, Omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial, Arch Neurol, 69, 1044, 10.1001/archneurol.2012.283 Pellizzer, 1999, Reduced dietary fat intake increases parasympathetic activity in healthy premenopausal women, Clin Exp Pharmacol Physiol, 26, 656, 10.1046/j.1440-1681.1999.03103.x Swank, 1991, Multiple sclerosis: fat–oil relationship, Nutrition, 7, 368 de Jonge, 2010, Impact of 6-month caloric restriction on autonomic nervous system activity in healthy, overweight, individuals, Obesity (Silver Spring), 18, 414, 10.1038/oby.2009.408 Stein, 2012, Caloric restriction may reverse age-related autonomic decline in humans, Aging Cell, 11, 644, 10.1111/j.1474-9726.2012.00825.x Monda, 2006, Activity of autonomic nervous system is related to body weight in pre-menopausal, but not in post-menopausal women, Nutr Neurosci, 9, 141, 10.1080/10284150600903552 Piccio, 2008, Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis, J Leukoc Biol, 84, 940, 10.1189/jlb.0208133 Saka, 2012, Nutritional status and anthropometric measurements of patients with multiple sclerosis, Saudi Med J, 33, 160 Messina, 2013, Autonomic nervous system in the control of energy balance and body weight: personal contributions, Neurol Res Int, 2013, 639280, 10.1155/2013/639280 Klaren, 2015, Impairment and disability in persons with MS: do functional performance or functional limitations matter?, Psychol Health Med, 1–7 Motl, 2015, Cardiorespiratory fitness and its association with thalamic, hippocampal, and basal ganglia volumes in multiple sclerosis, Neuroimage Clin, 7, 661, 10.1016/j.nicl.2015.02.017 Golzari, 2010, Combined exercise training reduces IFN-gamma and IL-17 levels in the plasma and the supernatant of peripheral blood mononuclear cells in women with multiple sclerosis, Int Immunopharmacol, 10, 1415, 10.1016/j.intimp.2010.08.008 Pilutti, 2011, Effects of 12weeks of supported treadmill training on functional ability and quality of life in progressive multiple sclerosis: a pilot study, Arch Phys Med Rehabil, 92, 31, 10.1016/j.apmr.2010.08.027 Cruickshank, 2015, A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease, Med (Baltimore), 94, e411, 10.1097/MD.0000000000000411 Coote, 2015, Pilot randomized trial of progressive resistance exercise augmented by neuromuscular electrical stimulation for people with multiple sclerosis who use walking aids, Arch Phys Med Rehabil, 96, 197, 10.1016/j.apmr.2014.09.021 Gehlsen, 1984, Effects of an aquatic fitness program on the muscular strength and endurance of patients with multiple sclerosis, Phys Ther, 64, 653, 10.1093/ptj/64.5.653 Woods, 2006, Exercise, inflammation, and innate immunity, Neurol Clin, 24, 585, 10.1016/j.ncl.2006.03.008 James, 2012, Heart rate variability: effect of exercise intensity on postexercise response, Res Q Exerc Sport, 83, 533 Lima, 2011, Acute effect of resistance exercise intensity in cardiac autonomic modulation after exercise, Arq Bras Cardiol, 96, 498, 10.1590/S0066-782X2011005000043 Leicht, 2008, Effect of exercise mode on heart rate variability during steady state exercise, Eur J Appl Physiol, 102, 195, 10.1007/s00421-007-0574-9 Goit, 2014, Mild-to-moderate intensity exercise improves cardiac autonomic drive in type 2 diabetes, J Diabetes Investig, 5, 722, 10.1111/jdi.12238 Baptista S1, 2008, Treadmill running and swimming imposes distinct cardiovascular physiological adaptations in the rat: focus on serotonergic and sympathetic nervous systems modulation, Acta Physiol Hung, 95, 365, 10.1556/APhysiol.2008.0002 Mathias, 2000, A 21st century water cure, Lancet, 356, 1046, 10.1016/S0140-6736(00)02723-9 Shannon, 2002, Water drinking as a treatment for orthostatic syndromes, Am J Med, 112, 355, 10.1016/S0002-9343(02)01025-2 Prinz-Zaiss, 1995, Power spectral analysis of heart rate variability during graded head-up tilting in patients with vasodepressor syncope, Clin Exp Pharmacol Physiol, 22, 472, 10.1111/j.1440-1681.1995.tb02048.x Sternberg, 2013, The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients, CNS Neurol Disord Drug Targets, 12, 104, 10.2174/1871527311312010016 Willer, 2005, Ebers GC and Canadian Collaborative Study G. Timing of birth and risk of multiple sclerosis: population based study, BMJ, 330, 120, 10.1136/bmj.38301.686030.63 Westberg, 2009, Occupational exposure to UV light and mortality from multiple sclerosis, Am J Ind Med, 52, 353, 10.1002/ajim.20682 Low, 2012, Vitamin D predicts MS in clinically isolated syndromes Smolders, 2008, Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis, Mult Scler, 14, 1220, 10.1177/1352458508094399 Ascherio, 2014, Vitamin D as an early predictor of multiple sclerosis activity and progression, JAMA Neurol, 71, 306, 10.1001/jamaneurol.2013.5993 Soilu-Hanninen, 2008, A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis, J Neurol Neurosurg Psychiatry, 79, 152, 10.1136/jnnp.2006.105320 Vojinovic, 2014, Vitamin D, receptor agonists' anti-inflammatory properties, Ann N Y Acad Sci, 1317, 47, 10.1111/nyas.12429 Stumpf, 1987, 1,25 (OH)2 vitamin D3 sites of action in the brain. An autoradiographic study, Histochemistry, 87, 393, 10.1007/BF00496810 Stumpf, 1988, 1,25(OH)2 vitamin D3 sites of action in spinal cord and sensory ganglion, Anat Embryol (Berl), 177, 307, 10.1007/BF00315837 Atchison, 2013, Vitamin D increases plasma renin activity independently of plasma Ca2+ via hypovolemia and beta-adrenergic activity, Am J Physiol Renal Physiol, 305, F1109, 10.1152/ajprenal.00010.2013 Peeyush Kumar, 2011, Expression of cholinergic, insulin, vitamin D receptors and GLUT 3 in the brainstem of streptozotocin induced diabetic rats: effect of treatment with vitamin D(3), Neurochem Res, 36, 2116, 10.1007/s11064-011-0536-9 Mann, 2013, Vitamin D levels are associated with cardiac autonomic activity in healthy humans, Nutrients, 5, 2114, 10.3390/nu5062114 Holick, 2007, Vitamin D, deficiency, N Engl J Med, 357, 266, 10.1056/NEJMra070553 Chan, 2010, Frequent hemodialysis Network Daily Trial Group. Determinants of cardiac autonomic dysfunction in ESRD, Clin J Am Soc Nephrol, 5, 1821, 10.2215/CJN.03080410 Salzer, 2013, Epstein–Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples, Mult Scler, 19, 1587, 10.1177/1352458513483888 Decard, 2012, Low vitamin D and elevated immunoreactivity against Epstein–Barr virus before first clinical manifestation of multiple sclerosis, J Neurol Neurosurg Psychiatry, 83, 1170, 10.1136/jnnp-2012-303068 Disanto, 2013, Vitamin D supplementation and antibodies against the Epstein–Barr virus in multiple sclerosis patients, Mult Scler, 19, 1679, 10.1177/1352458513494494 Varbiro, 2014, Lower-limb veins are thicker and vascular reactivity is decreased in a rat PCOS model: concomitant vitamin D3 treatment partially prevents these changes, Am J Physiol Heart Circ Physiol, 307, H848, 10.1152/ajpheart.01024.2013 Lee, 2014, Guideline. Diagnosis and treatment of venous malformations. Consensus document of the international union of phlebology (iup): updated-2013, Int Angiol, 28, 434 El Otmani, 2009, Cobalamin deficiency: neurological aspects in 27 cases, Rev Neurol (Paris), 165, 263, 10.1016/j.neurol.2008.10.013 Sucharita, 2012, Vitamin B12 supplementation improves heart rate variability in healthy elderly Indian subjects, Auton Neurosci, 168, 66, 10.1016/j.autneu.2011.12.002 Jaja, 2008, Electrocardiographic and blood pressure changes in apparently healthy male subjects following oral, chronic, low-dose vitamin C supplementation and/or change in posture, Nig Q J Hosp Med, 18, 96 Bruno, 2012, Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients, Am J Clin Nutr, 96, 302, 10.3945/ajcn.112.035022 Liao, 1995, Age, race, and sex differences in autonomic cardiac function measured by spectral analysis of heart rate variability—the ARIC study. Atherosclerosis risk in communities, Am J Cardiol, 76, 906, 10.1016/S0002-9149(99)80260-4 Mann, 2012, Impact of gender on the cardiac autonomic response to angiotensin II in healthy humans, J Appl Physiol (1985), 112, 1001, 10.1152/japplphysiol.01207.2011 Gautam, 2011, Comparison of cardiac autonomic functions among postmenopausal women with and without hormone replacement therapy, and premenopausal women, Indian J Physiol Pharmacol, 55, 297 Chaudhary, 2006, Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis, J Neuroimmunol, 175, 87, 10.1016/j.jneuroim.2006.03.007 Morini, 2004, Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis, J Neuroimmunol, 148, 146, 10.1016/j.jneuroim.2003.11.021 Santos, 2010, Alterations on monoamines concentration in rat hippocampus produced by lipoic acid, Arq Neuropsiquiatr, 68, 362, 10.1590/S0004-282X2010000300006 Yadav, 2005, Lipoic acid in multiple sclerosis: a pilot study, Mult Scler, 11, 159, 10.1191/1352458505ms1143oa Schillace, 2007, Lipoic acid stimulates cAMP production in T lymphocytes and NK cells, Biochem Biophys Res Commun, 354, 259, 10.1016/j.bbrc.2006.12.195 Salinthone, 2011, Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and-independent mechanisms, J Nutr Biochem, 22, 681, 10.1016/j.jnutbio.2010.05.008 Ziegler, 1997, Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie, Diabetes Care, 20, 369, 10.2337/diacare.20.3.369 Tomassini, 2004, Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial, J Neurol Sci, 218, 103, 10.1016/j.jns.2003.11.005 Jones, 2010, Acylcarnitines: role in brain, Prog Lipid Res, 49, 61, 10.1016/j.plipres.2009.08.004 Smeland, 2012, Chronic acetyl-l-carnitine alters brain energy metabolism and increases noradrenaline and serotonin content in healthy mice, Neurochem Int, 61, 100, 10.1016/j.neuint.2012.04.008 Garzya, 1990, Evaluation of the effects of l-acetylcarnitine on senile patients suffering from depression, Drugs Exp Clin Res, 16, 101 Guideri, 2005, Effects of acetyl-l-carnitine on cardiac dysautonomia in Rett syndrome: prevention of sudden death?, Pediatr Cardiol, 26, 574, 10.1007/s00246-005-0784-z Whedon, 2009, Cerebrospinal fluid stasis and its clinical significance, Altern Ther Health Med, 15, 54 Sanya, 2005, Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients, Clin Auton Res, 15, 213, 10.1007/s10286-005-0274-7 Gorucu, 2011, Cerebrospinal fluid flow dynamics in patients with multiple sclerosis: a phase contrast magnetic resonance study, Funct Neurol, 26, 215 Woods, 1961, A physical finding related to psychiatric disorders, J Am Osteopath Assoc, 60, 988 Upledger JE, 1983 Petrov, 2011, Safety profile of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis, J Endovasc Ther, 18, 314, 10.1583/11-3440.1 Hubbard, 2012, Clinical improvement after extracranial venoplasty in multiple sclerosis, J Vasc Interv Radiol, 23, 1302, 10.1016/j.jvir.2012.07.010 Salvi, 2012, Venous angioplasty in multiple sclerosis: neurological outcome at two years in a cohort of relapsing-remitting patients, Funct Neurol, 27, 55 Zamboni, 2012, Venous angioplasty in patients with multiple sclerosis: results of a pilot study, Eur J Vasc Endovasc Surg, 43, 116, 10.1016/j.ejvs.2011.03.035 Czura, 2005, Autonomic neural regulation of immunity, J Intern Med, 257, 156, 10.1111/j.1365-2796.2004.01442.x Pavlov, 2004, Neural regulators of innate immune responses and inflammation, Cell Mol Life Sci, 61, 2322, 10.1007/s00018-004-4102-3 Meerwijk, 2014, Psychological pain and reduced resting-state heart rate variability in adults with a history of depression, Psychophysiology, 51, 247, 10.1111/psyp.12175 Martinez-Martinez, 2014, Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case–control studies, J Clin Rheumatol, 20, 146, 10.1097/RHU.0000000000000089 Mallien, 2014, Sleep disturbances and autonomic dysfunction in patients with postural orthostatic tachycardia syndrome, Front Neurol, 5, 118, 10.3389/fneur.2014.00118 AP ACA, 2013 Cui, 2012, Limb venous distension evokes sympathetic activation via stimulation of the limb afferents in humans, Am J Physiol Heart Circ Physiol, 303, H457, 10.1152/ajpheart.00236.2012 Sternberg, 2013, Blood pressure normalization post-jugular venous balloon angioplasty, Phlebology, 30, 280, 10.1177/0268355513512824 Thibault, 2013, Objective duplex ultrasound evaluation of the extracranial circulation in multiple sclerosis patients undergoing venoplasty of internal jugular vein stenoses: a pilot study, Phlebology, 30, 98, 10.1177/0268355513515473 Zivadinov, 2013, Changes of cine cerebrospinal fluid dynamics in patients with multiple sclerosis treated with percutaneous transluminal angioplasty: a case–control study, J Vasc Interv Radiol, 24, 829, 10.1016/j.jvir.2013.01.490 Arata, 2014, Transvascular autonomic modulation: a modified balloon angioplasty technique for the treatment of autonomic dysfunction in multiple sclerosis patients, J Endovasc Ther, 21, 417, 10.1583/13-4605MR.1 Arata, 2015, Neuroendocrine responses to transvascular autonomic modulation, a modified balloon angioplasty in multiple sclerosis patients, Horm Metab Res